HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients.

AbstractOBJECTIVE:
The goal of this study was to examine the long-term outcomes of 53 epilepsy patients who were surgically treated for supratentorial cavernomas in a single-center study and to assess both the duration of epilepsy and the resection of the hemosiderin rim for their prognostic relevance during extended follow-up.
METHODS:
Fifty-three patients underwent microsurgical resection of radiologically diagnosed supratentorial cavernomas. For the outcome analysis, they were divided into 2 groups: Group A (33 patients) with a preoperative duration of epilepsy of less than 2 years, and Group B (20 patients) with a preoperative duration of epilepsy of 2 years or more. The natural history of the cavernomas, localization and size of the lesions, use of antiepileptic drugs, surgery timing, and technique (removal or not of the surrounding gliosis) were evaluated retrospectively. The outcome of epilepsy was based on Engel's classification and the International League Against Epilepsy classification.
RESULTS:
After a mean follow-up period of 8.1 years, 45 (84.9%) of the 53 patients were free from disabling seizures (Engel Class I), including 37 patients (69.8%) who were completely free of postoperative seizures (Engel Class IA); 43 patients (81.1%) were categorized as International League Against Epilepsy Class 1. Outcome was statistically significantly improved in the patient subgroup of our study in which patients underwent a resection of the surrounding gliosis after a preoperative duration of epilepsy of less than 2 years (Group A). There was no mortality, and only minor postoperative neurological deficits occurred in 7.5% of patients.
CONCLUSION:
In a long-term follow-up period, 84.9% of the patients in the study could be evaluated as Engel Class I. The analysis of outcome showed that patients benefited significantly from early surgery and excision of the hemosiderin rim.
AuthorsIoannis Stavrou, Christoph Baumgartner, Josa M Frischer, Siegfried Trattnig, Engelbert Knosp
JournalNeurosurgery (Neurosurgery) Vol. 63 Issue 5 Pg. 888-96; discussion 897 (Nov 2008) ISSN: 1524-4040 [Electronic] United States
PMID19005379 (Publication Type: Journal Article)
Chemical References
  • Hemosiderin
Topics
  • Adult
  • Epilepsy (classification, etiology, surgery)
  • Female
  • Follow-Up Studies
  • Gliosis (complications, surgery)
  • Hemangioma, Cavernous, Central Nervous System (complications, surgery)
  • Hemosiderin
  • Humans
  • Male
  • Microsurgery
  • Neurosurgical Procedures
  • Retrospective Studies
  • Sex Factors
  • Supratentorial Neoplasms (complications, surgery)
  • Time
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: